Search research articles
Contact Us
Filters
Showing results (71-80 of 81) with videos related to
Page
of 9
Sort By:
The Lancet. Oncology
|
May 2, 2024
International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma
Paula Rodriguez-Otero, Saad Usmani, Adam D Cohen, et al.
Blood
|
June 16, 2021
Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development
Daniel Alameda, Ibai Goicoechea, Marco Vicari, et al.
Blood Cancer Journal
|
May 22, 2021
Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial
Noemi Puig, Miguel T Hernández, Laura Rosiñol, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 27, 2019
Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma
Bruno Paiva, Noemi Puig, Maria-Teresa Cedena, et al.
Blood
|
June 11, 2025
High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 GEM trial
Juan-Jose Lahuerta, Jesús F San-Miguel, Ana Jiménez-Ubieto, et al.
The Journal of Pathology
|
February 22, 2018
Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemia
Maria J García-Barchino, Maria E Sarasquete, Carlos Panizo, et al.
Nature Communications
|
September 20, 2023
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance
Cirino Botta, Cristina Perez, Marta Larrayoz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2023
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies
Leire Burgos, Luis-Esteban Tamariz-Amador, Noemi Puig, et al.
Blood
|
July 22, 2020
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myeloma
Ibai Goicoechea, Noemi Puig, Maria-Teresa Cedena, et al.
Blood
|
January 29, 2026
Immune biomarkers of increased infection risk in multiple myeloma
Aintzane Zabaleta, Luis-Esteban Tamariz-Amador, Ioannis V Kostopoulos, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 81) with videos related to
Sort By:
Page
of 9
The Lancet. Oncology
|
May 2, 2024
International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma
Paula Rodriguez-Otero, Saad Usmani, Adam D Cohen, et al.
Blood
|
June 16, 2021
Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development
Daniel Alameda, Ibai Goicoechea, Marco Vicari, et al.
Blood Cancer Journal
|
May 22, 2021
Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial
Noemi Puig, Miguel T Hernández, Laura Rosiñol, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 27, 2019
Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma
Bruno Paiva, Noemi Puig, Maria-Teresa Cedena, et al.
Blood
|
June 11, 2025
High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 GEM trial
Juan-Jose Lahuerta, Jesús F San-Miguel, Ana Jiménez-Ubieto, et al.
The Journal of Pathology
|
February 22, 2018
Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemia
Maria J García-Barchino, Maria E Sarasquete, Carlos Panizo, et al.
Nature Communications
|
September 20, 2023
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance
Cirino Botta, Cristina Perez, Marta Larrayoz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2023
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies
Leire Burgos, Luis-Esteban Tamariz-Amador, Noemi Puig, et al.
Blood
|
July 22, 2020
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myeloma
Ibai Goicoechea, Noemi Puig, Maria-Teresa Cedena, et al.
Blood
|
January 29, 2026
Immune biomarkers of increased infection risk in multiple myeloma
Aintzane Zabaleta, Luis-Esteban Tamariz-Amador, Ioannis V Kostopoulos, et al.
Page
of 9